A major study from UVA Health reveals that severe cases of COVID-19 or influenza can alter immune cells in the lungs, creating conditions that promote cancer growth months or even years after recovery. Researchers found a 1.24-fold increase in lung cancer incidence among patients hospitalized for COVID-19, though mild cases showed no elevated risk.
The team led by immunologist Jie Sun discovered that neutrophils and macrophages — immune cells that normally defend the lungs — begin behaving abnormally after severe infection, fostering a persistent pro-tumor inflammatory environment. The mechanism essentially turns the body's own defenders into enablers of cancer development.
Critically, the study also found that vaccination can prevent many of these harmful immune changes, adding another reason for respiratory virus immunization. Researchers recommend that doctors closely monitor patients who recover from severe COVID, flu, or pneumonia so lung cancer can be caught early when treatment is most effective.
